WORLD-CLASS
ONCOLOGY
LOCAL ACCESS
Technology
Learn More
CyberKnife
Cyclotron
PET-CT Diagnostics
LINAC / Radixact

Approved by






Official authorization to operate a licensed medical center and provide clinical oncology services under national healthcare regulations.
See the Proof

01
Medical Activity License

02
Radiopharmacy / GMP License

03
Equipment Certification (CE / FDA)
Technology
Technology Stack

01
CyberKnife
Description:
Robotic Radiosurgery
(CyberKnife)
Robotic radiosurgery enables non-invasive, sub-millimeter-precision treatment of complex tumors using highly focused radiation beams. CyberKnife technology continuously tracks tumor motion in real time, adapting beam delivery to patient movement and anatomical changes without the need for rigid fixation or surgery.
This technology is particularly suited for small, complex, or hard-to-reach lesions and allows many treatments to be delivered in one or a few outpatient sessions. For patients, this means minimal disruption, no surgical recovery, and faster return to daily life. For the network, it provides a high-precision treatment modality that complements high-throughput radiotherapy while maintaining the highest clinical standards.
This technology is particularly suited for small, complex, or hard-to-reach lesions and allows many treatments to be delivered in one or a few outpatient sessions. For patients, this means minimal disruption, no surgical recovery, and faster return to daily life. For the network, it provides a high-precision treatment modality that complements high-throughput radiotherapy while maintaining the highest clinical standards.

02
Cyclotron & Radiopharmacy
Description:
In-house Cyclotron &
Radiopharmacy
The in-house cyclotron and radiopharmacy form the operational core of the diagnostic infrastructure. On-site production of short-lived radiopharmaceuticals eliminates dependence on external isotope logistics, stabilizes PET-CT scheduling, and significantly reduces variable costs. This autonomy transforms PET-CT from a bottleneck into a predictable, high-availability diagnostic service.
Radiopharmaceutical production follows GMP-aligned standards, with controlled synthesis, quality assurance, and batch traceability. By integrating isotope production directly into the center, New Era Medicine ensures consistent diagnostic quality, higher throughput, and full control over the critical first step of the oncology pathway.
Radiopharmaceutical production follows GMP-aligned standards, with controlled synthesis, quality assurance, and batch traceability. By integrating isotope production directly into the center, New Era Medicine ensures consistent diagnostic quality, higher throughput, and full control over the critical first step of the oncology pathway.

03
PET-CT Diagnostics
Description:
PET-CT Diagnostics
PET-CT is the entry point of the entire care pathway and the foundation of precision oncology. It combines metabolic imaging with anatomical detail, enabling early cancer detection, accurate staging, therapy planning, and objective assessment of treatment response. By visualizing tumor activity at the molecular level, PET-CT allows clinicians to identify disease earlier than conventional imaging and to precisely define target volumes for radiation therapy.

04
LINAC / Radixact
Description:
Advanced Radiotherapy
(LINAC / Radixact)
Advanced linear accelerator–based radiotherapy provides the backbone for high-volume cancer treatment. Using IMRT and VMAT techniques with integrated image guidance, modern LINAC systems deliver radiation precisely shaped to the tumor while minimizing exposure to surrounding healthy tissue.
High-throughput treatment capacity allows centers to serve large patient populations efficiently, while standardized planning, imaging, and quality assurance protocols maintain uniform treatment quality across locations. Together with radiosurgery and PET-CT, advanced radiotherapy completes a fully integrated diagnostic-to-treatment ecosystem.
High-throughput treatment capacity allows centers to serve large patient populations efficiently, while standardized planning, imaging, and quality assurance protocols maintain uniform treatment quality across locations. Together with radiosurgery and PET-CT, advanced radiotherapy completes a fully integrated diagnostic-to-treatment ecosystem.
Extended Technology Stack
CT-RT (Simulation CT)
MRI (Diagnostic & Planning Support)
Radiotherapy Planning Systems (TPS)
Image-Guided Radiotherapy (IGRT)
Radiopharmacy GMP Infrastructure
Network QA & Dosimetry Systems
AI Layer
AI-Driven Standardization

Diagnostics AI
Automated lesion detection, segmentation, and quantitative analysis to improve early diagnosis and ensure consistent PET-CT interpretation.
Planning AI
AI-assisted contouring and dose optimization that accelerates treatment planning while standardizing plan quality across centers.
Operations AI
Predictive scheduling, demand forecasting, and equipment monitoring to reduce downtime, shorten waiting times, and optimize throughput.
Platform Layer
A Simple Way to Support New Era Medicine
New Era Medicine platform lets you take part in the project in a clear and transparent way.

Buy NERA

View your contributions

Verified progress
Join the Platform


